MAIA Biotechnology Files 8-K
Ticker: MAIA · Form: 8-K · Filed: Oct 7, 2025 · CIK: 1878313
Sentiment: neutral
Topics: 8-K, regulatory-filing
TL;DR
MAIA Bio filed an 8-K on Oct 7, 2025. Details TBD.
AI Summary
MAIA Biotechnology, Inc. filed an 8-K on October 7, 2025, reporting other events and financial statements. The filing does not contain specific details about the nature of these events or any financial figures within the provided text.
Why It Matters
This filing indicates that MAIA Biotechnology, Inc. has made a regulatory submission, which could contain significant updates about the company's operations or financial status.
Risk Assessment
Risk Level: low — The filing is a standard 8-K for reporting events and exhibits, with no immediate indication of negative news or significant financial changes in the provided text.
Key Players & Entities
- MAIA Biotechnology, Inc. (company) — Registrant
- October 7, 2025 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of incorporation
- 001-41455 (identifier) — Commission File Number
- 444 West Lake Street, Suite 1700 (address) — Principal executive offices
- Chicago, IL (location) — City and State of principal executive offices
- 60606 (zip_code) — Zip code of principal executive offices
- 312-416-8592 (phone_number) — Registrant's telephone number
FAQ
What specific events are being reported in this 8-K filing?
The provided text indicates the filing is for 'Other Events' and 'Financial Statements and Exhibits' but does not specify the exact nature of these events.
When was this 8-K report filed?
The report was filed on October 7, 2025.
What is the principal executive office address for MAIA Biotechnology, Inc.?
The principal executive office is located at 444 West Lake Street, Suite 1700, Chicago, IL 60606.
What is the Commission File Number for MAIA Biotechnology, Inc.?
The Commission File Number is 001-41455.
What is the telephone number for MAIA Biotechnology, Inc.?
The telephone number is (312) 416-8592.
Filing Stats: 769 words · 3 min read · ~3 pages · Grade level 14.4 · Accepted 2025-10-07 08:58:45
Filing Documents
- form8-k.htm (8-K) — 41KB
- ex99-1.htm (EX-99.1) — 11KB
- ex99-1_001.jpg (GRAPHIC) — 3KB
- 0001493152-25-017222.txt ( ) — 224KB
- maia-20251007.xsd (EX-101.SCH) — 3KB
- maia-20251007_lab.xml (EX-101.LAB) — 33KB
- maia-20251007_pre.xml (EX-101.PRE) — 22KB
- form8-k_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Dated: October 7, 2025 MAIA BIOTECHNOLOGY, INC. By: /s/ Vlad Vitoc Name: Vlad Vitoc Title: Chief Executive Officer